Close

Regenerx Biopharma (RGRX) JV Commences Second Dry Eye Syndrome-Focused Phase 3 Trial

Go back to Regenerx Biopharma (RGRX) JV Commences Second Dry Eye Syndrome-Focused Phase 3 Trial